SCHEMBL3720193

SCHEMBL3720193

Cc1ccc(-c2cc(C(=O)O)cc(-n3c(C)nnc3C(C)C)c2)cc1.Cc1ccc(-c2cc(C(=O)O)cc(-n3c(C)nnc3C(C)C)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY14 Q15391 5/20 0.42
DHODH Q02127 1/20 0.42
CTRC Q99895 1/20 0.41
NR4A1 P22736 1/20 0.41
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
FABP1 P07148 1/20 0.38
P2RX3 P56373 1/20 0.36
P2RX2 Q9UBL9 1/20 0.36
KDM5A P29375 2/20 0.36
KDM4C Q9H3R0 2/20 0.36
KDM5B Q9UGL1 2/20 0.36
KDM4A O75164 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
MAP4K4 O95819 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2274756 1.00 P2RY14 (0.42) P2RY14DHODHCTRCNR4A1RXRA
SCHEMBL3720197 0.88 P2RX3 (0.35) P2RY14P2RX3P2RX2
SCHEMBL2271062 0.87 CYP11B1 (0.39) P2RX3P2RX2ALDH1A1MAPTTDP1
SCHEMBL4178348 0.86 P2RY14 (0.40) P2RY14DHODHCTRCNR4A1RXRA
SCHEMBL2275029 0.80
SCHEMBL4177211 0.80 P2RY14 (0.42) P2RY14DHODHCTRCNR4A1RXRA
SCHEMBL4051058 0.80 P2RX3 (0.46) P2RY14DHODHCTRCRXRARXRB
SCHEMBL2278513 0.78 DHODH (0.42) P2RY14DHODHCTRCNR4A1RXRA
SCHEMBL2271968 0.77 P2RX3 (0.66) P2RX3P2RX2
SCHEMBL3727443 0.77 DHODH (0.41) P2RY14DHODHCTRCNR4A1RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225213-A1 TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-08 EP disclosed
WO-2009077366-A1 TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed